|
|
|
|
| LEADER |
00000cam a2200000 7i4500 |
| 001 |
0000080326 |
| 008 |
120210s2012 ne eng |
| 020 |
|
|
|a 9780123919113
|
| 050 |
0 |
0 |
|a R853.C55
|b B76 2012
|
| 060 |
0 |
0 |
|a QV 771
|b B863c 2012
|
| 090 |
0 |
0 |
|a QV 771
|b B863c 2012
|
| 100 |
1 |
|
|a Brody, Tom
|e author
|
| 245 |
1 |
0 |
|a Clinical trials
|b study design, endpoints and biomarkers, drug safety, FDA and ICH guidelines
|c Tom Brody
|
| 260 |
|
|
|a Amsterdam
|a Boston
|b Elsevier/AP
|c 2012
|
| 300 |
|
|
|a xxxiii, 638 p.
|b ill.
|c 24 cm
|
| 650 |
|
0 |
|a Clinical trials
|
| 650 |
|
0 |
|a Drug approval
|
| 650 |
|
2 |
|a Clinical Trials as Topic
|
| 650 |
2 |
2 |
|a Clinical Trials Data Monitoring Committees
|
| 650 |
2 |
2 |
|a Drug Approval
|
| 650 |
2 |
2 |
|a Research Design
|
| 999 |
|
|
|a 1000149356
|b Book
|c OPEN SHELF (30 DAYS)
|e Medical Campus
|